BreezeBio Alternatives & Competitors
12 companies similar to BreezeBio — Genetic Medicine Delivered
Companies similar to BreezeBio
Aera Therapeutics
Enabling the next generation of transformative genetic medicines
NanoVation Therapeutics™
Delivering tomorrow's genetic medicines, today™
Rampart Bioscience
Leading a new era of effective, safe and accessible gene medicines.
ReCode Therapeutics
Powering the next wave of genetic medicines through superior delivery
Rival Readout
Competing with BreezeBio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Affinia Therapeutics
Building the next generation of gene therapies
Interius BioTherapeutics
Interius is developing new ways to engineer cells inside the human body, right where they...
Carbon Biosciences
Expanding Therapeutic Potential with Novel Parvovirus Gene Therapy
ReNAgade Therapeutics
RNA Without Limits
Laronde
Pioneering a completely novel translatable RNA platform - Endless RNA (eRNA)
Poseida Therapeutics, Inc.
A Member of the Roche Group
Capstan Therapeutics
Advancing cell engineering to develop therapeutics for a broad range of diseases
Anjarium Biosciences AG
DNA to Catalyze Your Advanced Therapies
About BreezeBio
GenEdit, a biotechnology startup founded in 2016 and headquartered in the United States, is pioneering solutions in the realm of genetic medicines with its innovative slogan: "Delivering the potential of genetic medicines". The company addresses a critical bottleneck in the field—effective delivery systems for genetic...
Development of Precision Genetic Medicines, Targeted Delivery of Genetic Payloads, Restoration of Immune Balance, Pipeline for Autoimmune and Oncology Therapies
Patients with Autoimmune Diseases, Healthcare Providers, Biotechnology Researchers, Pharmaceutical Companies
Genetic Medicines, Gene Therapy Delivery, Polymer Nanoparticles, Non-Viral Gene Editing, Therapeutic Candidates, NanoGalaxy Platform, Target Tissue Delivery, Gene Therapy Innovation, Non-Lipid Nanoparticles, Therapeutic Gene Editing, High Unmet Medical Need, Iterative Screening Process, Non-Viral Therapeutics, Genetic Disease Treatment, Safer Gene Editing
B2B, Platform
Licensing, Project Based, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around BreezeBio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at BreezeBio on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.